Introduction

Case report
Lipoprotein glomerulopathy is a rare condition characterized by abnormal lipoprotein deposition in glomer-A 16-year-old man presented with a 7-day history of uli, usually with lipoprotein thrombi distending and headache. Direct questioning revealed a 1-month hisoccluding glomerular capillary lumina, and with a tory of tiredness, breathlessness on exertion, ankle variable degree of mesangial proliferation [1] . First oedema, and blurred vision. There was no relevant described and most frequently reported in Japan [1] [2] [3] [4] [5] , past medical history. Family history was unremarkable it has been increasingly recognized in other racial apart from insulin-dependent diabetes mellitus and groups and in Europe over the past 10 years [6, 7] . The mild hypertension diagnosed in his father when aged usual presentation is with proteinuria or nephrotic 36. His parents were from Jamaica, but he had lived syndrome together with moderate renal impairment, all his life in the United Kingdom. Examination often with hypertension, and progressing in many cases showed a fit, well muscled man. Blood pressure was to renal failure. 268/168 on repeated measurement. Fundoscopy The aetiology of the condition is uncertain, although showed bilateral papilloedema with haemorrhages. it has been associated with increased apolipoprotein There was bilateral pitting oedema to the knees, small levels, an increased prevalence of the apolipoprotein pleural effusions, and moderate left ventricular hyper-E2/E3 phenotype, and with variable increases in serum trophy. Urinalysis showed 3+ protein and 1+ blood. cholesterol and triglycerides [1, [3] [4] [5] . One report sug-Remainder of examination was unremarkable. gests a familial predisposition [1 ] . It is clearly distinct Initial investigation showed sodium 134 mmol/l, from other causes of lipid accumulation within glomer-potassium 6.5 mmol/l, bicarbonate 16 mmol/l, urea uli, such as Gaucher's disease and other hereditary 39.9 mmol/l, and creatinine 1859 mmol/l. Creatinine sphingolipoidoses. Immunohistochemical analysis indi-phosphokinase and random glucose were not elevated. cates that the lipid deposits are composed mainly of He was appropriately anaemic with haemoglobin b/pre-b lipoprotein and that they represent accumula-8.7 g/dl, and normochromic normocytic indices. Blood tion of VLDL and/or remnants of VLDL derived from films showed minor fragmentation but no evidence of the plasma [6 ] . The factors which determine abnormal haemolysis. White cell count was normal, platelets deposition/accumulation are, however, unknown. 92×109/l. ESR was 71 mm in the first hour, C reactive Most reports suggest that the pathogenesis of the protein <4 u (normal <10 u), uric acid 0.63 mmol/l. condition is likely to be humoral in origin, rather than Tests of liver function and coagulation were normal specific to the kidney, although no other organ systems apart from an albumin of 31 mmol/l. He was nephrotic have yet been shown to be affected. Given this, the with 6.4 g/24-h proteinuria. Chest and abdominal recurrence of lipoprotein deposits and renal disease radiographs were unremarkable, while ECG showed following renal transplantation would be of great concentric left ventricular hypertrophy, confirmed on interest. An abstract presented to the Japanese Society echocardiography. Renal ultrasound showed 9.0-cm of Nephrology in 1989 suggested that this might indeed unobstructed kidneys with increased cortical echogenicity, and a small amount of ascitic fluid. Serological tests including antinuclear, antineutrophil cytoplasmic, were negative. Complement and immunoglobulin levels were normal. Infective and viral screens were negative.
Initial management consisted of control of hypertension with calcium antagonists, haemofiltration, optimization of fluid status, and insertion of a peritoneal dialysis catheter. He became oliguric despite adequate intravascular hydration. Catecholamine, steroid, and carcinoid screens were negative. Renal arteriograms showed no evidence of renovascular stenosis.
Percutaneous renal biopsy was performed on day 7. The findings were initially felt to be consistent with severe hypertension and long-standing ischaemic damage. On review, however, the diagnosis of lipoprotein glomerulopathy was established through special staining and a comparison with previously reported cases. Twenty-five glomeruli were present in the biopsy, 15 of which were totally sclerosed. The remainder showed expansion of the glomerular tuft by lipid-laden Fig. 2 . Native renal biopsy. A different glomerulus at a higher power cells, variable mesangial expansion, and a minor degree showing expansion of the mesangium by lipid-laden cells (arrows). of accumulation of lipid deposits in tubular epithelial H&E stain. Bar represents 40 mm. cells (Figures 1 and 2 ). There were no interstitial foam cells. Blood vessels showed marked hypertensive changes with areas of intraglomerular thrombosis and this was determined. Investigations of his lipid status showed fasting cholesterol 3.6 mmol/l, triglycerides necrosis but no vasculitis, whilst the tubulointerstitial compartment showed severe chronic damage with cel-0.7 mmol/l, and apolipoprotein E3/3 phenotype. Fasting glucose was 3.9 mmol/l. He was blood group O+, with lular casts and tubular atrophy. Amyloid staining and immunofluoresence for IgG, IgA, IgM, C3, and fibrin tissue type A 1,23 B 7 Bw 6 Cw 2 DR 3,7 Drw 52,53 DQ2. Lecithin-cholesterol aclytransferase activity was were negative. Electron-microscopy confirmed arterial hypertrophy, lipid-laden macrophages in glomeruli, within the normal range and other lipoidoses were excluded by history and clinical examination. and an absence of immune deposits.
The patient was established on continuous ambulatFive months after presentation, the patient received a cadaveric renal transplant. The donor was a 29-yearory peritoneal dialysis, his blood pressure controlled, and he was worked up for transplantation. Over this old man who had died from partially treated bacterial meningitis. Immunosuppression was with tacrolimus, period, persistent mild eosinophilia was noted, with an absolute eosinophil count 0.5-1.0×109/l. No cause for prednisolone, and azathioprine. Initial function was excellent, with a nadir creatinine of 105 mmol/l, while proteinuria fell to 1.9 g/24 h. Subsequently the patient developed insulin-dependent diabetes and two episodes of unexplained abdominal pain, both of which were attributed to tacrolimus. From 4 months onwards, there was a gradual rise in serum creatinine from 110 to 135 mmol/l. Increasing proteinuria was also recorded, peaking at 7.7 g/24 h, and suggesting the possibility of a recurrent disease process. There was no haematuria. Transplant biopsy was performed 7 months after transplantation. A small sample of cortex contained five glomeruli. There was no evidence of glomerulonephritis, amyloid, or rejection. Three glomeruli showed increased mesangial matrix, giving a rather solid appearance with a proliferation of cells at the periphery of the tuft and in Bowman's space (Figure 3 ) . The remaining two glomeruli showed increased cellularity throughout the tuft, with a lesser increase in matrix. The cells in Bowman's space had foamy cytoplasm, with fat demonstrable in the glomerular tuft using Oil Red O staining. These changes had not been present in a donor biopsy taken the time of transplantation. The tubules and blood vessels were factors such as HLA typing are associated with disease incidence or progression. These details are provided in our patient for future reference.
Optimal treatment for lipoprotein glomerulopathy remains uncertain. Trials of immunosuppression, antiplatelet drugs, fibrinolytics, lipid-lowering drugs, and glucocorticoids have all proved ineffective, albeit in very small numbers of patients [2, 6, 7, 9 ] . Although one case report suggests that probucol may be effective in minimizing disease progression, the patient described had coincident IgA nephropathy and an unusual apolipoprotein E phenotype [10 ] . A second patient treated with probucol showed no improvement, and the majority of case reports have shown no response to this or other lipid-lowering agents. Given this, the efficacy of any form of therapy or prophylaxis has yet to be confirmed, and our patient received no specific treatment other than our normal post-transplant immunosuppression.
This case is instructive in two other respects. The sion, with implications for therapy and transplantation; and that it may develop rapidly despite relatively normal negative. Overall, the appearances were very similar to plasma lipids, measured on several occasions. This latter those seen in the original biopsy, and were interpreted feature makes screening for disease problematic, even to reflect recurrence of the original disease process.
within family groups, and may caution against the use The patient is well at 12 month follow-up. He of living related transplant donors. Much remains to be remains insulin dependent with normal albumin and determined about both the natural history and the early liver function, trough tacrolimus levels 5-6 ng/l, and presentation of this condition, and further wellserum cholesterol which has risen to 6.4 mmol/l. Renal documented reports are required. function is impaired and gradually declining, with urea currently 6.4 mmol/l, creatinine 156 mmol/l, and
